# OnCo record ready-dasatinib (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/ready-dasatinib/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "ready-dasatinib", "NCT00744497" ;
  schema:name "READY"@en ;
  schema:alternateName "READY"@en, "CA180-227"@en, "dasatinib with docetaxel"@en ;
  schema:description "Blocking Src, the kinase that lets prostate cancer cells talk to bone-dissolving cells, did nothing when added to chemotherapy."@en ;
  schema:url <https://onco.cc/trials/ready-dasatinib/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00744497>, <https://doi.org/10.1016/S1470-2045(13)70479-0> ;
  onco:status "negative" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-mcrpc/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:targets <https://onco.cc/targets/src/> ;
  onco:drugs <https://onco.cc/drugs/dasatinib/>, <https://onco.cc/drugs/docetaxel/>, <https://onco.cc/drugs/prednisone/> ;
  onco:companies <https://onco.cc/companies/bms/> ;
  onco:terms <https://onco.cc/terms/bone-metastases/>, <https://onco.cc/terms/castration-resistance/> ;
  onco:trials <https://onco.cc/trials/comet-1/>, <https://onco.cc/trials/calgb-90401/>, <https://onco.cc/trials/swog-s0421-atrasentan/> .